
Opinion|Videos|August 28, 2024
Treatment Options for Central Precocious Puberty
Key opinion leaders analyze current treatment guidelines for Central Precocious Puberty while offering insights on navigating treatment selection in scenarios lacking established protocols.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you review current guidelines for treatment of CPP?
- What are the therapies currently available for CPP?
- Can you provide insights on how you navigate treatment selection and approach without available guidelines?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA expands antithrombin III (human) label to pediatric patients with rare blood-clotting disorder
2
Olivia Kim-McManus, MD, discusses genetic testing, therapy in pediatric neurology
3
FDA accepts roflumilast cream 0.3% sNDA to treat plaque psoriasis in children 2 to 5 years
4
Roflumilast Efficacy and Safety in Pediatric AD
5










